{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:38:36Z","timestamp":1774417116905,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG002132"],"award-info":[{"award-number":["AG002132"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG031220"],"award-info":[{"award-number":["AG031220"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mary Jane Brinton Fund","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100011756","name":"Sherman Fairchild Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100011756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0703-9","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T11:03:22Z","timestamp":1558350202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human \u03b1-synuclein"],"prefix":"10.1186","volume":"7","author":[{"given":"Zuzana","family":"Krejciova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-5498","authenticated-orcid":false,"given":"Stanley B.","family":"Prusiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"key":"703_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jmb.2006.02.007","volume":"358","author":"M Anderson","year":"2006","unstructured":"Anderson M, Bocharova OV, Makarava N, Breydo L, Salnikov VV, Baskakov IV (2006) Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J Mol Biol 358:580\u2013596","journal-title":"J Mol Biol"},{"key":"703_CR2","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1523\/JNEUROSCI.1192-05.2005","volume":"25","author":"SJ Barmada","year":"2005","unstructured":"Barmada SJ, Harris DA (2005) Visualization of prion infection in transgenic mice expressing green fluorescent protein-tagged prion protein. J Neurosci 25:5824\u20135832","journal-title":"J Neurosci"},{"key":"703_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-015-0254-7","volume":"3","author":"ME Bernis","year":"2015","unstructured":"Bernis ME, Babila JT, Breid S, W\u00fcsten KA, W\u00fcllner U, Tamg\u00fcney G (2015) Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol Commun 3:75","journal-title":"Acta Neuropathol Commun"},{"key":"703_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","volume":"171","author":"G Bj\u00f8rk\u00f8y","year":"2005","unstructured":"Bj\u00f8rk\u00f8y G, Lamark T, Brech A, Outzen H, Perander M, \u00d8vervatn A, Stenmark H, Johansen T (2005) p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171:603\u2013614","journal-title":"J Cell Biol"},{"key":"703_CR5","first-page":"797","volume":"199","author":"M Bourdenx","year":"2015","unstructured":"Bourdenx M, Dehay B, Bezard E (2015) Experimental modelling of \u03b1-synuclein aggregation and spreading in synucleinopathies. Bull Acad Natl Med 199:797\u2013808","journal-title":"Bull Acad Natl Med"},{"key":"703_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pneurobio.2015.07.003","volume":"155","author":"M Bourdenx","year":"2017","unstructured":"Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A (2017) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol 155:171\u2013193","journal-title":"Prog Neurobiol"},{"key":"703_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"703_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol 114:231\u2013241","journal-title":"Acta Neuropathol"},{"key":"703_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2004.02.026","volume":"26","author":"DE Cabin","year":"2005","unstructured":"Cabin DE, Gispert-Sanchez S, Murphy D, Auburger G, Myers RR, Nussbaum RL (2005) Exacerbated synucleinopathy in mice expressing A53T SNCA on a SNCA null background. Neurobiol Aging 26:25\u201335","journal-title":"Neurobiol Aging"},{"key":"703_CR10","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R et al (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22:8797\u20138807","journal-title":"J Neurosci"},{"key":"703_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0092-8674(86)90875-5","volume":"46","author":"GA Carlson","year":"1986","unstructured":"Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S, Westaway D, Prusiner SB (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:503\u2013511","journal-title":"Cell"},{"key":"703_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nbd.2017.04.011","volume":"103","author":"F Cavaliere","year":"2017","unstructured":"Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M, Bessede A, Obeso JA, Matute C, Ichas F et al (2017) In vitro \u03b1-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Neurobiol Dis 103:101\u2013112","journal-title":"Neurobiol Dis"},{"key":"703_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1471-4159.2009.06191.x","volume":"110","author":"K-Y Chau","year":"2009","unstructured":"Chau K-Y, Ching HL, Schapira AHV, Cooper JM (2009) Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis. J Neurochem 110:1005\u20131013","journal-title":"J Neurochem"},{"key":"703_CR14","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1172\/JCI35314","volume":"119","author":"L Chen","year":"2009","unstructured":"Chen L, Periquet M, Wang X, Negro A, McLean PJ, Hyman BT, Feany MB (2009) Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest 119:3257\u20133265","journal-title":"J Clin Invest"},{"key":"703_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/joim.12029","volume":"273","author":"SJ Chinta","year":"2013","unstructured":"Chinta SJ, Lieu CA, DeMaria M, Laberge R-M, Campisi J, Andersen JK (2013) Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson\u2019s disease? J Intern Med 273:429\u2013436","journal-title":"J Intern Med"},{"key":"703_CR16","doi-asserted-by":"publisher","first-page":"a020370","DOI":"10.1101\/cshperspect.a020370","volume":"7","author":"W-S Chung","year":"2015","unstructured":"Chung W-S, Allen NJ, Eroglu C (2015) Astrocytes control synapse formation, function, and elimination. Cold Spring Harb Perspect Biol 7:a020370","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"703_CR17","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/0006-291X(78)91249-4","volume":"81","author":"A Ciehanover","year":"1978","unstructured":"Ciehanover A, Hod Y, Hershko A (1978) A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun 81:1100\u20131105","journal-title":"Biochem Biophys Res Commun"},{"key":"703_CR18","unstructured":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division of Earth and Life Sciences, National Research Council of the National Academies (2011) Guide for the Care and Use of Laboratory Animals. The National Academies Press, Washington, DC"},{"key":"703_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-006-0119-z","volume":"112","author":"E Croisier","year":"2006","unstructured":"Croisier E, Graeber MB (2006) Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol 112:517\u2013530","journal-title":"Acta Neuropathol"},{"key":"703_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","volume":"14","author":"B Dehay","year":"2015","unstructured":"Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, Singleton A, Olanow CW, Merchant KM, Bezard E et al (2015) Targeting \u03b1-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations. Lancet Neurol 14:855\u2013866","journal-title":"Lancet Neurol"},{"key":"703_CR21","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1074\/jbc.M010316200","volume":"276","author":"CE Ellis","year":"2001","unstructured":"Ellis CE, Schwartzberg PL, Grider TL, Fink DW, Nussbaum RL (2001) \u03b1-Synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J Biol Chem 276:3879\u20133884","journal-title":"J Biol Chem"},{"key":"703_CR22","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K (2010) Cell-produced \u03b1-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838\u20136851","journal-title":"J Neurosci"},{"key":"703_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4161\/auto.19085","volume":"8","author":"S Engelender","year":"2012","unstructured":"Engelender S (2012) \u03b1-Synuclein fate: proteasome or autophagy? Autophagy 8:418\u2013420","journal-title":"Autophagy"},{"key":"703_CR24","doi-asserted-by":"publisher","first-page":"e1005623","DOI":"10.1371\/journal.ppat.1005623","volume":"12","author":"C Fang","year":"2016","unstructured":"Fang C, Imberdis T, Garza MC, Wille H, Harris DA (2016) A neuronal culture system to detect prion synaptotoxicity. PLoS Pathog 12:e1005623","journal-title":"PLoS Pathog"},{"key":"703_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N (2013) Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia 61:349\u2013360","journal-title":"Glia"},{"key":"703_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"703_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"Hideo Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nature Cell Biology"},{"key":"703_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34:521\u2013533","journal-title":"Neuron"},{"key":"703_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-6606-3-12","volume":"3","author":"X-L Gu","year":"2010","unstructured":"Gu X-L, Long C-X, Sun L, Xie C, Lin X, Cai H (2010) Astrocytic expression of Parkinson's disease-related A53T \u03b1-synuclein causes neurodegeneration in mice. Mol Brain 3:12","journal-title":"Mol Brain"},{"key":"703_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH (2011) Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord 26:6\u201317","journal-title":"Mov Disord"},{"key":"703_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/1074-5521(95)90071-3","volume":"2","author":"H Han","year":"1995","unstructured":"Han H, Weinreb PH, Lansbury PT Jr (1995) The core Alzheimer\u2019s peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol 2:163\u2013169","journal-title":"Chem Biol"},{"key":"703_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1365-2990.2001.00345.x","volume":"27","author":"N Hishikawa","year":"2001","unstructured":"Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease. Neuropathol Appl Neurobiol 27:362\u2013372","journal-title":"Neuropathol Appl Neurobiol"},{"key":"703_CR33","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM-Y, Clark CM, Glosser G, Stern MB, Gollomp SM et al (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54:1916\u20131921","journal-title":"Neurology"},{"key":"703_CR34","doi-asserted-by":"publisher","first-page":"e95958","DOI":"10.1371\/journal.pone.0095958","volume":"9","author":"WS Jackson","year":"2014","unstructured":"Jackson WS, Krost C, Borkowski AW, Kaczmarczyk L (2014) Translation of the prion protein mRNA is robust in astrocytes but does not amplify during reactive astrocytosis in the mouse brain. PLoS One 9:e95958","journal-title":"PLoS One"},{"key":"703_CR35","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/mds.20537","volume":"20","author":"KA Jellinger","year":"2005","unstructured":"Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20:S29\u2013S36","journal-title":"Mov Disord"},{"key":"703_CR36","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","volume":"131","author":"M Komatsu","year":"2007","unstructured":"Komatsu M, Waguri S, Koike M, Sou Y-S, Ueno T, Hara T, Mizushima N, Iwata J-I, Ezaki J, Murata S et al (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131:1149\u20131163","journal-title":"Cell"},{"key":"703_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/bpa.12536","volume":"27","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Lee VM, Trojanowski JQ (2017) Protein astrogliopathies in human neurodegenerative diseases and aging. Brain Pathol 27:675\u2013690","journal-title":"Brain Pathol"},{"key":"703_CR38","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1084\/jem.20161547","volume":"214","author":"Z Krejciova","year":"2017","unstructured":"Krejciova Z, Alibhai J, Zhao C, Krencik R, Rzechorzek NM, Ullian EM, Manson J, Ironside JW, Head MW, Chandran S (2017) Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner. J Exp Med 214:3481\u20133495","journal-title":"J Exp Med"},{"key":"703_CR39","first-page":"1","volume":"122","author":"HA Kretzschmar","year":"1986","unstructured":"Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ (1986) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122:1\u20135","journal-title":"Am J Pathol"},{"key":"703_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S, Przuntek H, Epplen JT, Sch\u00f6ls L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"703_CR41","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","volume":"19","author":"YM Kuo","year":"2010","unstructured":"Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD et al (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19:1633\u20131650","journal-title":"Hum Mol Genet"},{"key":"703_CR42","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/00001756-200107200-00009","volume":"12","author":"E Kuusisto","year":"2001","unstructured":"Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 12:2085\u20132090","journal-title":"Neuroreport"},{"key":"703_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nature05290","volume":"443","author":"PT Lansbury","year":"2006","unstructured":"Lansbury PT, Lashuel HA (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443:774\u2013779","journal-title":"Nature"},{"key":"703_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4161\/oxim.3.4.12809","volume":"3","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Kim C, Lee S-J (2010) Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection. Oxidative Med Cell Longev 3:283\u2013287","journal-title":"Oxidative Med Cell Longev"},{"key":"703_CR45","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"H-J Lee","year":"2005","unstructured":"Lee H-J, Patel S, Lee S-J (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25:6016\u20136024","journal-title":"J Neurosci"},{"key":"703_CR46","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Suk J-E, Patrick C, Bae E-J, Cho J-H, Rho S, Hwang D, Masliah E, Lee S-J (2010) Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262\u20139272","journal-title":"J Biol Chem"},{"key":"703_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","volume":"52","author":"VM-Y Lee","year":"2006","unstructured":"Lee VM-Y, Trojanowski JQ (2006) Mechanisms of Parkinson's disease linked to pathological \u03b1-synuclein: new targets for drug discovery. Neuron 52:33\u201338","journal-title":"Neuron"},{"key":"703_CR48","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1111\/j.1471-4159.2007.04904.x","volume":"103","author":"FRS Lima","year":"2007","unstructured":"Lima FRS, Arantes CP, Muras AG, Nomizo R, Brentani RR, Martins VR (2007) Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem 103:2164\u20132176","journal-title":"J Neurochem"},{"key":"703_CR49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/nn1988","volume":"10","author":"CS Lobsiger","year":"2007","unstructured":"Lobsiger CS, Cleveland DW (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10:1355\u20131360","journal-title":"Nat Neurosci"},{"issue":"5","key":"703_CR50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","volume":"134","author":"Frida Loria","year":"2017","unstructured":"Loria F, Vargas JY, Bousset L, Syan S, Salles A, Melki R, Zurzolo C (2017) \u03b1-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathol 134:789\u2013808","journal-title":"Acta Neuropathologica"},{"key":"703_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/path.1711550105","volume":"155","author":"J Lowe","year":"1988","unstructured":"Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 155:9\u201315","journal-title":"J Pathol"},{"key":"703_CR52","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, Lee VMY (2012) Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med 209:975\u2013986","journal-title":"J Exp Med"},{"key":"703_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncpneuro0355","volume":"2","author":"NJ Maragakis","year":"2006","unstructured":"Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2:679\u2013689","journal-title":"Nat Clin Pract Neurol"},{"key":"703_CR54","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136:1128\u20131138","journal-title":"Brain"},{"key":"703_CR55","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1074\/mcp.M800116-MCP200","volume":"7","author":"MA McFarland","year":"2008","unstructured":"McFarland MA, Ellis CE, Markey SP, Nussbaum RL (2008) Proteomics analysis identifies phosphorylation-dependent \u03b1-synuclein protein interactions. Mol Cell Proteomics 7:2123\u20132137","journal-title":"Mol Cell Proteomics"},{"key":"703_CR56","first-page":"217","volume":"5","author":"R Melki","year":"2015","unstructured":"Melki R (2015) Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases. J Park Dis 5:217\u2013227","journal-title":"J Park Dis"},{"key":"703_CR57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/sj.mp.4000446","volume":"3","author":"E Mezey","year":"1998","unstructured":"Mezey E, Dehejia AM, Harta G, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH (1998) Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol Psychiatry 3:493\u2013499","journal-title":"Mol Psychiatry"},{"key":"703_CR58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","volume":"197","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Doudet DD, Schwab C, Yu S, McGeer EG, McGeer PL (2006) Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp Neurol 197:275\u2013283","journal-title":"Exp Neurol"},{"key":"703_CR59","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","volume":"112","author":"DW Miller","year":"2005","unstructured":"Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB (2005) Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 112:1613\u20131624","journal-title":"J Neural Transm"},{"key":"703_CR60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1006\/exnr.2002.7929","volume":"176","author":"F Mori","year":"2002","unstructured":"Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K (2002) Demonstration of \u03b1-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol 176:98\u2013104","journal-title":"Exp Neurol"},{"key":"703_CR61","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0896-6273(95)90307-0","volume":"14","author":"M Moser","year":"1995","unstructured":"Moser M, Colello RJ, Pott U, Oesch B (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14:509\u2013517","journal-title":"Neuron"},{"key":"703_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/neup.12243","volume":"36","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H et al (2016) Accumulation of phosphorylated \u03b1-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration. Neuropathology 36:157\u2013167","journal-title":"Neuropathology"},{"key":"703_CR63","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1006\/bbrc.2000.4253","volume":"280","author":"T Nakamura","year":"2001","unstructured":"Nakamura T, Yamashita H, Takahashi T, Nakamura S (2001) Activated Fyn phosphorylates \u03b1-synuclein at tyrosine residue 125. Biochem Biophys Res Commun 280:1085\u20131092","journal-title":"Biochem Biophys Res Commun"},{"key":"703_CR64","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2990.2004.00564.x","volume":"30","author":"M Nishie","year":"2004","unstructured":"Nishie M, Mori F, Yoshimoto M, Takahashi H, Wakabayashi K (2004) A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 30:546\u2013554","journal-title":"Neuropathol Appl Neurobiol"},{"key":"703_CR65","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.275.1.390","volume":"275","author":"M Okochi","year":"2000","unstructured":"Okochi M, Walter J, Koyama A, Nakajo S, Baba M, Iwatsubo T, Meijer L, Kahle PJ, Haass C (2000) Constitutive phosphorylation of the Parkinson's disease associated \u03b1-synuclein. J Biol Chem 275:390\u2013397","journal-title":"J Biol Chem"},{"key":"703_CR66","doi-asserted-by":"publisher","first-page":"12571","DOI":"10.1073\/pnas.0906759106","volume":"106","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Prusiner SB (2009) Is Parkinson\u2019s disease a prion disorder? Proc Natl Acad Sci U S A 106:12571\u201312572","journal-title":"Proc Natl Acad Sci U S A"},{"key":"703_CR67","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.90.23.10962","volume":"90","author":"K-M Pan","year":"1993","unstructured":"Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE et al (1993) Conversion of \u03b1-helices into \u03b2-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90:10962\u201310966","journal-title":"Proc Natl Acad Sci U S A"},{"key":"703_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and shy-Drager syndrome). J Neurol Sci 94:79\u2013100","journal-title":"J Neurol Sci"},{"key":"703_CR69","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jnc.13595","volume":"139","author":"W Peelaerts","year":"2016","unstructured":"Peelaerts W, Baekelandt V (2016) \u03b1-Synuclein strains and the variable pathologies of synucleinopathies. J Neurochem 139:256\u2013274","journal-title":"J Neurochem"},{"issue":"7556","key":"703_CR70","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W. Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344","journal-title":"Nature"},{"key":"703_CR71","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC et al (2018) Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557:558\u2013563","journal-title":"Nature"},{"key":"703_CR72","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"703_CR73","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","volume":"47","author":"SB Prusiner","year":"2013","unstructured":"Prusiner SB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47:601\u2013623","journal-title":"Annu Rev Genet"},{"key":"703_CR74","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A 112:E5308\u2013E5317","journal-title":"Proc Natl Acad Sci U S A"},{"key":"703_CR75","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1093\/emboj\/16.20.6057","volume":"16","author":"AJ Raeber","year":"1997","unstructured":"Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, Mucke L, Manson J, Aguzzi A, Oldstone MBA et al (1997) Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J 16:6057\u20136065","journal-title":"EMBO J"},{"key":"703_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","volume":"16","author":"EH Rannikko","year":"2015","unstructured":"Rannikko EH, Weber SS, Kahle PJ (2015) Exogenous \u03b1-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci 16:57","journal-title":"BMC Neurosci"},{"key":"703_CR77","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","volume":"37","author":"J Rostami","year":"2017","unstructured":"Rostami J, Holmqvist S, Lindstr\u00f6m V, Sigvardson J, Westermark GT, Ingelsson M, Bergstr\u00f6m J, Roybon L, Erlandsson A (2017) Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci 37:11835\u201311853","journal-title":"J Neurosci"},{"key":"703_CR78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-015-0029-4","volume":"10","author":"NJ Rutherford","year":"2015","unstructured":"Rutherford NJ, Sacino AN, Brooks M, Ceballos-Diaz C, Ladd TB, Howard JK, Golde TE, Giasson BI (2015) Studies of lipopolysaccharide effects on the induction of \u03b1-synuclein pathology by exogenous fibrils in transgenic mice. Mol Neurodegener 10:32","journal-title":"Mol Neurodegener"},{"key":"703_CR79","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.1523\/JNEUROSCI.2102-14.2014","volume":"34","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, McKinney AB, Thomas MA, Shaw G, Golde TE, Giasson BI (2014) Brain injection of \u03b1-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J Neurosci 34:12368\u201312378","journal-title":"J Neurosci"},{"key":"703_CR80","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jnc.14139","volume":"143","author":"D Sargent","year":"2017","unstructured":"Sargent D, Verch\u00e8re J, Lazizzera C, Gaillard D, Lakhdar L, Streichenberger N, Morignat E, B\u00e9temps D, Baron T (2017) \u2018Prion-like\u2019 propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum. J Neurochem 143:126\u2013135","journal-title":"J Neurochem"},{"key":"703_CR81","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1021\/acschemneuro.6b00287","volume":"8","author":"A Sidhu","year":"2017","unstructured":"Sidhu A, Segers-Nolten I, Raussens V, Claessens MM, Subramaniam V (2017) Distinct mechanisms determine \u03b1-synuclein fibril morphology during growth and maturation. ACS Chem Neurosci 8:538\u2013547","journal-title":"ACS Chem Neurosci"},{"key":"703_CR82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","volume":"12","author":"ZA Sorrentino","year":"2017","unstructured":"Sorrentino ZA, Brooks MMT, Hudson V III, Rutherford NJ, Golde TE, Giasson BI, Chakrabarty P (2017) Intrastriatal injection of \u03b1-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity. Mol Neurodegener 12:40","journal-title":"Mol Neurodegener"},{"key":"703_CR83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205\u2013208","journal-title":"Neurosci Lett"},{"key":"703_CR84","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"703_CR85","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, Mollenhauer B, Schneider A (2016) Induction of \u03b1-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Brain 139:481\u2013494","journal-title":"Brain"},{"key":"703_CR86","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2016.04.052","volume":"165","author":"LO Sun","year":"2016","unstructured":"Sun LO, Barres BA (2016) Glia get neurons in shape. Cell 165:775\u2013776","journal-title":"Cell"},{"key":"703_CR87","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10522-014-9532-1","volume":"15","author":"FCC Tan","year":"2014","unstructured":"Tan FCC, Hutchison ER, Eitan E, Mattson MP (2014) Are there roles for brain cell senescence in aging and neurodegenerative disorders? Biogerontology 15:643\u2013660","journal-title":"Biogerontology"},{"key":"703_CR88","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","volume":"288","author":"SA Tanik","year":"2013","unstructured":"Tanik SA, Schultheiss CE, Volpicelli-Daley LA, Brunden KR, Lee VMY (2013) Lewy body-like \u03b1-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem 288:15194\u201315210","journal-title":"J Biol Chem"},{"key":"703_CR89","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/bpa.12214","volume":"25","author":"K Tanji","year":"2015","unstructured":"Tanji K, Odagiri S, Miki Y, Maruyama A, Nikaido Y, Mimura J, Mori F, Warabi E, Yanagawa T, Ueno S et al (2015) p62 deficiency enhances \u03b1-synuclein pathology in mice. Brain Pathol 25:552\u2013564","journal-title":"Brain Pathol"},{"key":"703_CR90","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/brain\/awm097","volume":"130","author":"TC Thannickal","year":"2007","unstructured":"Thannickal TC, Lai Y-Y, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130:1586\u20131595","journal-title":"Brain"},{"key":"703_CR91","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410440324","volume":"44","author":"PH Tu","year":"1998","unstructured":"Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble \u03b1-synuclein. Ann Neurol 44:415\u2013422","journal-title":"Ann Neurol"},{"key":"703_CR92","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/030098589503200312","volume":"32","author":"LJ Van Keulen","year":"1995","unstructured":"Van Keulen LJ, Schreuder BE, Meloen RH, Poelen-van den Berg M, Mooij-Harkes G, Vromans ME, Langeveld JP (1995) Immunohistochemical detection and localization of prion protein in brain tissue of sheep with natural scrapie. Vet Pathol 32:299\u2013308","journal-title":"Vet Pathol"},{"key":"703_CR93","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3727\/096368915X687750","volume":"24","author":"N Vardjan","year":"2015","unstructured":"Vardjan N, Verkhratsky A, Zorec R (2015) Pathologic potential of astrocytic vesicle traffic: new targets to treat neurologic diseases? Cell Transplant 24:599\u2013612","journal-title":"Cell Transplant"},{"key":"703_CR94","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1002\/cne.24040","volume":"524","author":"CS Von Bartheld","year":"2016","unstructured":"Von Bartheld CS, Bahney J, Herculano-Houzel S (2016) The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol 524:3865\u20133895","journal-title":"J Comp Neurol"},{"key":"703_CR95","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99:14\u201320","journal-title":"Acta Neuropathol"},{"key":"703_CR96","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) \u03b1-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180\u2013182.","journal-title":"Neurosci Lett"},{"key":"703_CR97","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn.2016.13","volume":"17","author":"DM Walsh","year":"2016","unstructured":"Walsh DM, Selkoe DJ (2016) A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci 17:251\u2013260","journal-title":"Nat Rev Neurosci"},{"key":"703_CR98","doi-asserted-by":"publisher","first-page":"e52868","DOI":"10.1371\/journal.pone.0052868","volume":"7","author":"Y Watanabe","year":"2012","unstructured":"Watanabe Y, Tatebe H, Taguchi K, Endo Y, Tokuda T, Mizuno T, Nakagawa M, Tanaka M (2012) p62\/SQSTM1-dependent autophagy of Lewy body-like \u03b1-synuclein inclusions. PLoS One 7:e52868","journal-title":"PLoS One"},{"key":"703_CR99","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1073\/pnas.1318268110","volume":"110","author":"JC Watts","year":"2013","unstructured":"Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, DeArmond SJ, Prusiner SB (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A 110:19555\u201319560","journal-title":"Proc Natl Acad Sci U S A"},{"key":"703_CR100","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00401-004-0935-y","volume":"109","author":"GK Wenning","year":"2005","unstructured":"Wenning GK, Jellinger KA (2005) The role of \u03b1-synuclein in the pathogenesis of multiple system atrophy. Acta Neuropathol 109:129\u2013140","journal-title":"Acta Neuropathol"},{"key":"703_CR101","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21465","volume":"64","author":"GK Wenning","year":"2008","unstructured":"Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG (2008) Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 64:239\u2013246","journal-title":"Ann Neurol"},{"key":"703_CR102","doi-asserted-by":"publisher","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","volume":"112","author":"AL Woerman","year":"2015","unstructured":"Woerman AL, St\u00f6hr J, Aoyagi A, Rampersaud R, Krejciova Z, Watts JC, Ohyama T, Patel S, Widjaja K, Oehler A et al (2015) Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci U S A 112:E4949\u2013E4958","journal-title":"Proc Natl Acad Sci U S A"},{"key":"703_CR103","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/aps.2013.29","volume":"34","author":"F Yang","year":"2013","unstructured":"Yang F, Yang Y-P, Mao C-J, Liu L, Zheng H-F, Hu L-F, Liu C-F (2013) Crosstalk between the proteasome system and autophagy in the clearance of \u03b1-synuclein. Acta Pharmacol Sin 34:674\u2013680","journal-title":"Acta Pharmacol Sin"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0703-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0703-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0703-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:16:04Z","timestamp":1589843764000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0703-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0703-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"15 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animals were maintained in an AAALAC-accredited facility in compliance with the Guide for the Care and Use of Laboratory Animals. All procedures used in this study were approved by the University of California, San Francisco, Institutional Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have read and approved the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Institute for Neurodegenerative Diseases has a research collaboration with Daiichi Sankyo (Tokyo, Japan). S.B.P. is a member of the Scientific Advisory Board of ViewPoint Therapeutics, which has\u00a0not contributed financial or any other support to these studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"81"}}